GoodRx Holdings
GDRX
162 hedge funds and large institutions have $342M invested in GoodRx Holdings in 2026 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 27 closing their positions.
101% more call options, than puts
Call options by funds: $2.95M | Put options by funds: $1.47M
47% more capital invested
Capital invested by funds: $232M → $342M (+$110M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
4.53% more ownership
Funds ownership: 108.9% → 113.42% (+4.5%)
0% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 50
8% less funds holding
Funds holding: 176 → 162 (-14)
41% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$4.23M |
| 2 |
Two Sigma Investments
New York
|
+$1.41M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.38M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.33M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
-$1.69M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$1.46M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.01M |
| 4 |
State Street
Boston,
Massachusetts
|
-$982K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$946K |
GDRX Hedge Fund Activity: Q2 2026 in Review
162 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2026, worth a combined $342M — up 47% from $232M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of GDRX and 16 opened new positions — a net loss of 11 holders — while 50 trimmed existing stakes and 50 added.
The largest buyer was Jane Street, adding an estimated $4.23M. The largest seller was Moore Capital Management, cutting an estimated $1.69M.
- 162 institutional investors held GoodRx Holdings (GDRX) as of Q2 2026, down from 176 in Q1 2026.
- Funds reported $342M of GoodRx Holdings stock for Q2 2026, up 47% quarter-over-quarter.
- 16 funds opened new GoodRx Holdings positions in Q2 2026 and 27 closed out, a net change of -11 holders.
- The largest GoodRx Holdings buyer in Q2 2026 was Jane Street, an estimated $4.23M added.
- The largest GoodRx Holdings seller in Q2 2026 was Moore Capital Management, an estimated $1.69M sold.
Based on aggregated 13F filings for Q2 2026.